BeStock  
Stocks › Biotechnology › STOK

Stoke Therapeutics STOK

US equityMarket cap rank #2926Biotechnology
$25.32 −$0.30 (-1.17%)
Pre-market · Oct 6, 4:10 am ET · After hours $25.32 0.00%
Open$25.82
Prev close$25.62
Day range$24.84 – $26.31
Volume928.4K
Market cap$1.63B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$9.33M-32.5% YoY
Operating profit-$65.43M-139.7% YoY
Net profit-$61.62M-162.4% YoY
Diluted EPS-$0.93-132.5% YoY

Revenue, last 8 quarters

$4.9MSep '24$22.6MDec '24$158.6MMar '25$13.8MJun '25$10.6MSep '25$1.4MDec '25$6.2MMar '26$9.3MJun '26

Net profit, last 8 quarters

$-26.4MSep '24$-10.5MDec '24$112.9MMar '25$-23.5MJun '25$-38.3MSep '25$-57.9MDec '25$-50.0MMar '26$-61.6MJun '26

Diluted EPS by quarter

-0.47Sep '24-0.18Dec '241.90Mar '25-0.40Jun '25-0.65Sep '25-1.00Dec '25-0.79Mar '26-0.93Jun '26

Profitability & balance sheet

Operating margin-809.7%
Net margin-753.6%
Return on equity-61.1%
Return on assets-53.4%
Return on invested capital-60.7%
Current ratio7.69

Income statement

Line item 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2
Net Non-Operating Interest Income (Expense) $3.50M $3.40M $3.62M $3.46M $3.79M
Operating Profit -$65.43M -$53.42M -$61.44M -$43.09M -$27.30M
Research & Development $49.50M $39.67M $41.70M $37.70M $25.86M
-General & Admin Expense $25.25M $19.97M – – $15.26M
Selling and Admin Expenses $25.25M $19.97M $21.15M $16.03M $15.26M
Operating Expense $74.75M $59.65M $62.84M $53.72M $41.12M
Total Operating Revenue $9.33M $6.23M $1.40M $10.63M $13.82M
Total Revenue as Reported $9.33M $6.23M $1.40M $10.63M $13.82M
Total Other Finance Costs -$3.50M -$3.40M -$3.62M -$3.46M -$3.79M
Other Income (Expense) $308,000.00 $18,000.00 -$110,000.00 $3,000.00 $28,000.00
Diluted EPS -$0.93 -$0.79 -$1.00 -$0.65 -$0.40
Basic EPS -$0.93 -$0.79 -$1.00 -$0.65 -$0.40
Net Income to Common Stockholders -$61.62M -$50.00M -$57.93M -$38.35M -$23.48M
Net Income to Parent Company -$61.62M -$50.00M -$57.93M -$38.35M -$23.48M
Net Profit -$61.62M -$50.00M -$57.93M -$38.35M -$23.48M
Tax $0.00 $0.00 – -$1.28M $0.00
Pretax Profit -$61.62M -$50.00M -$57.93M -$39.63M -$23.48M
Other Non-Operating Income (Expenses) $308,000.00 $18,000.00 -$110,000.00 $3,000.00 $28,000.00
Profit from Continuing Operations -$61.62M -$50.00M -$57.93M -$38.35M -$23.48M

Discussion

No comments yet — be the first to weigh in on STOK.

Leave a comment

Scroll to Top